Lease of BacT/Alert Virtuo Blood Culture System Includes Reagents and Maintenance Service

Where this opportunity stands

Every notice posted under solicitation HT941025Q2066 in this department, oldest first.

Next steps for this stage

Standard steps for the notice type; not advice about this buyer.

• Decide bid or no bid before the response deadline.
• Look at the past winners for likely competitors and teaming partners.
• Follow the opportunity to hear about amendments and the award.

What the notice says

Who won similar work

12 award notices on SAM.gov in the last 24 months. Matched by: Same office (DEFENSE HEALTH AGENCY HCD WEST), same NAICS 334516.

Single-winner award sizes (12): middle half $100K to $2.8M, median $876K; range $39K to $5.7M.

Value counts single-winner awards. "Shared" awards are multiple-award contracts that list every winner with the same total ceiling; that ceiling is not one company's win, so it is not added in. Revenue next to a ticker is the company's last annual revenue from its 10-K.

• Oct 1, 2026SYSMEX AMERICA, INC$2.7MFY26 Lab Consolidation for Coagulation CPRR EffortNo listed company matched (Materiality N/A)
• Sep 25, 2026QUIDELORTHO SALES COMPANY$5.7MDry Chemistry AnalyzersMateriality: 0.21% of $QDEL revenue (Low)Calculated as Award Amount divided by the company's trailing twelve-month revenue (SEC 10-Q). Here: $5.7M award ÷ $2.7B revenue, 12 months to Jun 28, 2026 (SEC 10-Q). SEC
• Sep 17, 2026GOVERNMENT SCIENTIFIC SOURCE INC$937KBIORAD Quality Control MaterialsNo listed company matched (Materiality N/A)
• Jul 17, 2026PHADIA US INC$1.3MPhadia Analyzer 250Materiality: <0.01% of $TMO revenue (Low)Calculated as Award Amount divided by the company's trailing twelve-month revenue (SEC 10-Q). Here: $1.3M award ÷ $46.3B revenue, 12 months to Jun 27, 2026 (SEC 10-Q). SEC
• Apr 8, 2026BIOFIRE DEFENSE LLC$4.7MBIOFIRE MOLECULAR ANALYZER AT NHCPNo listed company matched (Materiality N/A)
• Apr 8, 2026ADVANCED INSTRUMENTS LLC$39KBR2 Bilirubin Stat Analyzer for NHC HawaiiNo listed company matched (Materiality N/A)
• Dec 9, 2025ABBOTT LABORATORIES INC.$814KChemistry and Immunoassay TestingMateriality: <0.01% of $ABT revenue (Low)Calculated as Award Amount divided by the company's trailing twelve-month revenue (SEC 10-Q). Here: $814K award ÷ $45.1B revenue, 12 months to Mar 31, 2026 (SEC 10-Q). SEC
• Dec 9, 2025SYSMEX AMERICA, INC$111KSole Source - Hematology Analyzer, JBPHHNo listed company matched (Materiality N/A)
• Sep 29, 2025AGILENT TECHNOLOGIES JAPAN, LTD.$67KAgilent 8890 Gas Chromatography systemNo listed company matched (Materiality N/A)
• Sep 3, 2025ORTHO-CLINICAL DIAGNOSTICS, INC$3.0MCost-Per-Test Immunohematology Testing at Nellis, Travis and Naval Medical Center San DiegoMateriality: 0.11% of $QDEL revenue (Low)Calculated as Award Amount divided by the company's trailing twelve-month revenue (SEC 10-Q). Here: $3.0M award ÷ $2.7B revenue, 12 months to Jun 28, 2026 (SEC 10-Q). SEC

Materiality: one award's value as a share of the winner's revenue over the latest 12 months in its SEC filings (or its last fiscal year, as noted when you point at it). Low under 1%, Medium 1 to 5%, High 5% or more. Many awards are paid over several years, so this overstates a single year's share.

Competitive landscape

For the 8 most frequent past winners above. Lobbying is matched by the company's exact name or exact ticker; agencies are as named on the filings.

Policy around it

Bills the past winners named while lobbying this agency's issues, rules from the department, and executive orders that name the agency, last 12 months.

Market

For past winners matched exactly to a listed company. Insider trades are open-market buys and sells (Form 4) in the last 90 days, shown as facts; our own study found insiders do not reliably buy ahead of awards. A sale marked 10b5-1 was made under a trading plan set up in advance.